Skip to main content

Peer Review reports

From: A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

Original Submission
30 Aug 2021 Submitted Original manuscript
8 Oct 2021 Reviewed Reviewer Report
10 Oct 2021 Reviewed Reviewer Report
17 Oct 2021 Reviewed Reviewer Report
17 Oct 2021 Reviewed Reviewer Report
24 Nov 2021 Author responded Author comments - Jorge B. Cannata-Andía
Resubmission - Version 2
24 Nov 2021 Submitted Manuscript version 2
5 Dec 2021 Reviewed Reviewer Report
12 Dec 2021 Reviewed Reviewer Report
14 Dec 2021 Reviewed Reviewer Report
18 Dec 2021 Reviewed Reviewer Report
29 Dec 2021 Author responded Author comments - Jorge B. Cannata-Andía
Resubmission - Version 3
29 Dec 2021 Submitted Manuscript version 3
1 Jan 2022 Reviewed Reviewer Report
3 Jan 2022 Reviewed Reviewer Report
15 Jan 2022 Reviewed Reviewer Report
22 Jan 2022 Author responded Author comments - Jorge B. Cannata-Andía
Resubmission - Version 4
22 Jan 2022 Submitted Manuscript version 4
27 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
9 Feb 2022 Editorially accepted
18 Feb 2022 Article published 10.1186/s12916-022-02290-8

You can find further information about peer review here.

Back to article page